InMed Pharmaceuticals, Inc. (INM)
1.54
+0.03
(+1.99%)
USD |
NASDAQ |
Jun 11, 12:25
InMed Pharmaceuticals Market Cap : 5.104M for June 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 10, 2026 | 5.004M |
| June 09, 2026 | 5.071M |
| June 08, 2026 | 5.104M |
| June 05, 2026 | 5.236M |
| June 04, 2026 | 5.17M |
| June 03, 2026 | 5.269M |
| June 02, 2026 | 5.037M |
| June 01, 2026 | 5.17M |
| May 29, 2026 | 5.203M |
| May 28, 2026 | 5.568M |
| May 27, 2026 | 5.501M |
| May 26, 2026 | 5.700M |
| May 22, 2026 | 5.700M |
| May 21, 2026 | 5.733M |
| May 20, 2026 | 5.336M |
| May 19, 2026 | 5.303M |
| May 18, 2026 | 2.256M |
| May 15, 2026 | 2.121M |
| May 14, 2026 | 2.154M |
| May 13, 2026 | 2.101M |
| May 12, 2026 | 2.171M |
| May 11, 2026 | 2.058M |
| May 08, 2026 | 2.154M |
| May 07, 2026 | 2.308M |
| May 06, 2026 | 2.120M |
| Date | Value |
|---|---|
| May 05, 2026 | 2.160M |
| May 04, 2026 | 2.184M |
| May 01, 2026 | 2.086M |
| April 30, 2026 | 2.102M |
| April 29, 2026 | 2.046M |
| April 28, 2026 | 2.046M |
| April 27, 2026 | 2.139M |
| April 24, 2026 | 2.252M |
| April 23, 2026 | 2.225M |
| April 22, 2026 | 2.268M |
| April 21, 2026 | 2.106M |
| April 20, 2026 | 2.111M |
| April 17, 2026 | 2.073M |
| April 16, 2026 | 2.043M |
| April 15, 2026 | 2.080M |
| April 14, 2026 | 2.086M |
| April 13, 2026 | 2.080M |
| April 10, 2026 | 2.089M |
| April 09, 2026 | 1.880M |
| April 08, 2026 | 1.888M |
| April 07, 2026 | 1.986M |
| April 06, 2026 | 2.028M |
| April 02, 2026 | 1.979M |
| April 01, 2026 | 1.957M |
| March 31, 2026 | 1.883M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| NervGen Pharma Corp. | 144.16M |
| Milestone Pharmaceuticals, Inc. | 149.01M |
| Manzo Pharmaceuticals, Inc. | 0.116M |
| Clearmind Medicine, Inc. | 0.516M |
| Pharmagreen Biotech, Inc. | 0.6913M |
Market Cap Related Metrics
| PS Ratio | 1.656 |
| Price to Book Value | 0.7405 |
| Price | 1.54 |
| Earnings Yield | -167.2% |